Orexo initiates exploratory feasibility studies of amorphOX® with two leading biopharmaceutical and vaccine companies ...Middle East

PR Newswire - News
Orexo has successfully formulated Covid-19 spike protein in the proprietary drug delivery platform amorphOX®, showing excellent protein stability Orexo has initiated two exploratory feasibility studies applying amorphOX® to a protein based pharmaceutical and a vaccine in collaboration...

Hence then, the article about orexo initiates exploratory feasibility studies of amorphox with two leading biopharmaceutical and vaccine companies was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Orexo initiates exploratory feasibility studies of amorphOX® with two leading biopharmaceutical and vaccine companies )

Apple Storegoogle play

Last updated :

Also on site :



Latest News